Absci Corporation (ABSI) Financials

ABSI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 236.3 million 39.9 million
2023-06-30 254.2 million 38.8 million
2023-03-31 295.8 million 41.8 million
2022-12-31 321.0 million 46.6 million

ABSI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -10.7 million 2.5 million
2023-06-30 -19.5 million 3.0 million
2023-03-31 -20.4 million 2.7 million
2022-12-31 -19.1 million 1.0 million

ABSI Net Income

No data available :(

ABSI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 113.5 million - 9.0 million
2023-06-30 124.6 million 6.4 million 9.9 million
2023-03-31 144.3 million 7.2 million 11.0 million
2022-12-31 164.4 million - 12.1 million

ABSI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 92.2 million
2023-06-30 91.8 million
2023-03-31 91.5 million
2022-12-31 91.3 million

ABSI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 307000 11.0 million 9.5 million -
2023-06-30 256000 12.1 million 9.4 million -
2023-03-31 280000 12.7 million 9.6 million -
2022-12-31 560000 11.3 million 7.7 million -

ABSI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 744000 3.5 million
2023-06-30 3.4 million 3.5 million
2023-03-31 1.3 million 3.5 million
2022-12-31 1.6 million 3.6 million

ABSI

Price: $5.08

52 week price:
1.11
6.59

Earnings Per Share: -1.20 USD

P/E Ratio: -3.71

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 382100

Market Capitalization: 579.7 million

Links: